Intestinal anti-inflammatory activity of esculetin and 4-methylesculetin in the trinitrobenzenesulphonic acid model of rat colitis

Chemico-Biological Interactions

Volumn 186, Issue 2, 2010, Pages 211-218

  Witaicenis, Aline ^a   Seito, Leonardo N ^a   Di Stasi, Luiz C ^a  

^a SÃO PAULO STATE UNIVERSITY UNESP   (Brazil)

Author keywords

4 Methylesculetin; Coumarin; Esculetin; Inflammatory bowel disease; TNBS

Indexed keywords

4 METHYLESCULETIN; ALKALINE PHOSPHATASE; COUMARIN DERIVATIVE; ESCULETIN; GLUTATHIONE; MYELOPEROXIDASE; SALAZOSULFAPYRIDINE; TRINITROBENZENESULFONIC ACID; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIINFLAMMATORY ACTIVITY; ANTIOXIDANT ACTIVITY; ARTICLE; COLITIS; COLON INJURY; COLON MUCOSA; CONTROLLED STUDY; DIARRHEA; DRUG EFFICACY; DRUG STRUCTURE; ENZYME ACTIVITY; ENZYME INHIBITION; EXPERIMENTAL MODEL; MALE; NONHUMAN; ORGAN WEIGHT; PROTEIN CONTENT; RAT; STRUCTURE ACTIVITY RELATION;

ALKALINE PHOSPHATASE; ANIMALS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; ANTIOXIDANTS; COLITIS; DISEASE MODELS, ANIMAL; GLUTATHIONE; MALE; PEROXIDASE; RATS; RATS, WISTAR; SCOPOLETIN; STRUCTURE-ACTIVITY RELATIONSHIP; SULFASALAZINE; TRINITROBENZENESULFONIC ACID; UMBELLIFERONES;

RATTUS;

EID: 77953537918     PISSN: 00092797     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cbi.2010.03.045     Document Type: Article

References (60)

1. Katz J.A., Itoh J., Fiocchi C. Pathogenesis of inflammatory bowel disease. Curr. Opin. Gastroenterol. 1999, 15:291-297.
2. Magnani M., Crinelli R., Bianchi M., Antonelli A. The ubiquitin-dependent proteolytic system and other potential targets for the modulation of nuclear factor-kB (NF-kB). Curr. Drug Targets 2000, 1:387-399.
3. Kruidenier L., Kuiper I., Van Duijn W., Mieremet-Ooms M.A., van Hogezand R.A., Lamers C.B., Verspaget H.W. Imbalanced secondary mucosal antioxidant response in inflammatory bowel disease. J. Pathol. 2003, 201:17-27.
4. Grisham M.B. Oxidants and free radicals in inflammatory bowel disease. Lancet 1994, 344:859-861.
5. Ahnfelt-Ronne I., Haagen Nielsen O., Christensen A., Langholz E., Binder V., Riis P. Clinical evidence supporting the radical scavenger mechanism of 5-aminosalicylic acid. Gastroenterology 1990, 98:1162-1169.
6. Gálvez J., Sánchez de Medina F., Jimenez J., Zarzuelo A. Effects of flavonoids on gastrointestinal disorders. Studies in natural products chemistry 2001, vol. 25:607-649. Elsevier Science, Amsterdam.
7. Gonzáles R., Sánches de Medina F., Gálvez J., Rodríguez-Cabeza M.E., Duarte J., Zarzuelo A. Dietary vitamin E supplementation protects the rat large intestine from experimental inflammation. Int. J. Vitam. Nutr. Res. 2001, 71:243-250.
8. Cuzzocrea S., Mc Donald M.C., Masón E., Dugo L., Lepore V., Fonti M.T., Ciccolo A., Terranova M.L., Caputi A.P., Thiemermann C. Tempol, a membrane permeable radical scavenger, reduces dinitrobenzene sulfonic acid-induced colitis. Eur. J. Pharmacol. 2000, 406:27-37.
9. Di Stasi L.C., Camuesco D., Nieto A., Vilegas W., Zarzuelo A., Galvez J. Intestinal anti- inflammatory activity of Paepalantine, an isocumarin isolated from the capitula of Paepalanthus bromelioides, in the trinitrobenzenesulfhonic acid model of rat colitis. Planta Med. 2004, 70:315-320.
10. Luchini A.C., Rodrigues-Orsi P., Cestari S.H., Seito L.N., Witaicenis A., Pellizzon C.H., Di Stasi L.C. Intestinal anti-inflammatory activity of coumarin and 4-hydroxycoumarin in the trinitrobenzenosulphonic acid model of rat colitis. Biol. Pharm. Bull. 2008, 37(1):1343-1350.
11. Hoult J.R.S., Forder R.A., Heras B., Lobo I., Payá M. Inhibitory activity of a series of coumarins on leukocyte eicosanoid generation. Agents Actions 1994, 42:44-49.
12. Payá M., Halliwell B., Hoult J.R.S. Interactions of a series of coumarins with reactive oxygen species. Scavenging of superoxide, hypochlorous acid and hydroxyl radicals. Biochem. Pharmacol. 1992, 44(2):205-214.
13. Lin W.L., Wang .C.J., Tsai Y.Y., Liu C.L., Hwang J.M., Tseng T.H. Inhibitory effect of esculetin on oxidative damage induced by t-butyl hydroperoxide in rat liver. Arch. Toxicol. 2000, 74:467-472.
14. Kostova I. Synthetic and natural coumarins as cytotoxic agents. Curr. Med. Chem. 2005, 5:29-46.
15. Riveiro M.E., Moglioni A., Vazquez R., Gomez N., Facorro G., Piehl L., Celis E.R., Shayo C., Davio C. Structural insights into hydroxycoumarin-induced apoptosis in U-937 cells. Bioorg. Med. Chem. 2008, 16:2665-2675.
16. Kaneko T., Tahara S., Takabayashi F. Suppression of lipid hydroperoxide-induced oxidative damage to cellular DNA by esculetin. Biol. Pharm. Bull. 2003, 26:840-844.
17. Tubaro A., Negro P.D., Ragazzi E., Zampiron S., Loggia R.D. Antiinflammatory and peripheral analgesic activity of esculetin in vivo. Pharmacol. Res. Commum 1998, 20:83-85.
18. Leung K.N., Leung P.Y., Kong L.P., Leung P.K. Immunomodulatory effects of esculetin (6,7-dihydroxycoumarin) on murine lymphocytes and peritoneal macrophages. Mol. Immunol. 2005, 2:181-188.
19. Kuo H.C., Lee H.J., Hu C.C., Shun H.I., Tseng T.H. Enhancement of esculetin on taxol-induced apoptosis in human hepatoma HepG2 cells. Toxicol. Appl. Pharm. 2006, 210:55-62.
20. Kok S.H., Yeh C.C., Chen M.L., Kuo M.Y.P. Esculetin enhances TRAIL-induced apoptosis through DR5 upregulation in human oral cancer SAS cells. Oral Oncol. 2009, 10.1016/j.oraloncology.2009.07.018.
21. Mabalirajan U., Dinda A.K., Sharma S.K., Ghosh B. Esculetin restores mitochondrial dysfunction and reduces allergic asthma features in experimental murine model. J. Immunol. 2009, 183:2059-2067.
22. Okada Y., Miyauchi N., Suzuki K., Kobayashi T., Tsutsui C., Mayuzumi K., Nishibe S., Okuyama T. Inhibitory effect of coumarin and flavonoids derivates on bovine reductase and rabbit platelet aggregation. Chem. Pharm. Bull. 1995, 43:1385-1387.
23. Yamada H., Watanabe K., Saito T., Hayashi H., Niitani Y., KiKuchi T., Ito A., Fujikawa K., Lohmander L.S. Esculetin (dihydroxycoumarin) inhibits the production of matrix metalloproteinases in cartilage explants, and oral administration of its prodrug, CPA-926, suppresses cartilage destruction in rabbit experimental osteoarthritis. J. Rheumatol. 1999, 26(3):654-662.
24. Watanabe K., Ito A., Sato T., Hayashi H., Niitani Y. Esculetin suppresses proteoglycan metabolism by inhibiting the production of matriz metalloproteinases in rabbit chondrocytes. Eur. J. Pharmacol. 1999, 16:297-305. (Erratum in: Eur. J. Pharmacol. 379 (2-3) (1999) 379-243).
25. Wang C.J., Hsieh Y.J., Chu C.Y., Lin Y.L., Tseng T.H. Inhibition of cell cycle progression in human leukemia HL-60 cells by esculetin. Cancer Lett. 2002, 183:163-168.
26. Hu Y., Chen X., Duan H., Hu Y., Mu X. Chinese herbal medicinal ingredients inhibit secretion of IL-6, IL-8, E-selectin and TXB2 in LPS-induced rat intestinal microvascular endothelial cells. Immunopharmacol. Immunotoxicol. 2009, 31(4):550-555.
27. Bettini V., Caló L., Cantaro S., Martino R., Munari L., Salvatico E., Ton P. Liberation of prostaglandin-like substances from the isolated coronary artery in presence of angiotensin and of 4-methylesculetin. Acta Vitaminol. Enzymol. 1985, 7(3-4):257-267.
28. Hajime M., Shuichi Y., Makoto N., Masanori Y., Ikuko K., Atsushi K., Mutsuo S., Keiichi T. Inhibitory effect of 4-methylesculetin on hyaluronan synthesis slows the development of human pancreatic cancer in vitro and in nude mice. Int. J. Cancer 2007, 120:2704-2709.
29. Morris G.P., Beck P.L., Herridge W., Depew W., Szcewczuk M.R., Wallace J.L. Hapten-induced model of chronic inflammation and ulceration in the rat colon. Gastroenterology 1989, 96:795-803.
30. Bell C.J., Gall D.G., Wallace J.L. Disruption of colonic electrolyte transport in experimental colitis. Am. J. Physiol. 1995, 268:G622-G630.
31. Krawisz J.E., Sharon P., Stenson W.F. Quantitative assay for acute intestinal inflammation based on myeloperoxidase activity. Assessment of inflammation in the rat and hamster model. Gastroenterology 1984, 87:1344-1350.
32. Bessey O.A., Lowry O.H., Brock M.J. A method for the rapid determination of alkaline phosphatase with five cubic millimeters of serum. J. Biol. Chem. 1946, 164:321-329.
33. Anderson M.E. Determination of glutathione and glutathione disulfide in biological samples. Methods Enzymol. 1985, 113:548-555.
34. Gálvez J., Cruz J.P., Zarzuelo A., Sanches de la Cuesta F. Flavonoid inhibition of enzymic and nonenzymic lipid peroxidation in rat liver differ from its influence on the glutathione-related enzymes. Pharmacology 1995, 51:127-133.
35. Kruidenier L., Verspaget H.W. Review article: oxidative stress as a pathogenic factor in inflammatory bowel disease-radicals or ridiculous?. Aliment. Pharmacol. Ther. 2002, 16:1997-2015.
36. Pavlick K.P., Laroux F.S., Fuseler J., Wolf R.E., Gray L., Hoffman J., Grisham M.B. Role of reactive metabolites of oxygen and nitrogen in inflammatory bowel disease. Free Radic. Bio. Med. 2002, 33:311-322.
37. Buffinton D.G., Doe W.F. Depleted mucosal antioxidant defences in inflammatory bowel disease. Free Radic. Bio. Med. 1995, 19:911-918.
38. Wirtz S., Neurath M.F. Animal models of intestinal inflammation: new insights into the molecular pathogenesis and immunotherapy of inflammatory bowel disease. Int. J. Colorectal Dis. 2000, 15:144-160.
39. Sánchez de Medina F., Gálvez J., Romero J.A., Zarzuelo A. Effect of quercetrin on the early stages of hapten induced colonic inflammation in the rat. Life Sci. 2002, 70:3097-3108.
40. Yamada T., Marshall S., Specian R.D., Grisham M.B. A comparative study of two models of experimental colitis in rats. Gastroenterology 1992, 102:1524-1534.
41. Villegas I., La Casa C., Orjales A., Alarcón de la C., Lastra Effects of dosmalfate, a new cytoprotective agent, on acute and chronic trinitrobenzene sulphonic acid-induced colitis in rats. Eur. J. Pharmacol. 2003, 460:209-218.
42. Veljaca M., Lesch C.A., Pllana R., Sanches B., Chan K., Guglietta A. BPC-15 reduces trinitrobenzenesulfonic-induced colonic damage in rats. J. Pharmacol. Exp. Ther. 1995, 272:417-422.
43. Sánchez de Medina F., Gálvez J., Romero J.A., Zarzuelo A. Effect of quercitrin on acute and chronic experimental colitis in the rat. J. Pharm. Exp. Ther. 1996, 278:771-779.
44. Sánchez de Medina F., Martinez-Augustin O., González R., Ballester I., Nieto A., Gálvez J., Zarzuelo A. Induction of alkaline phosphatase in the inflamed intestine: a novel pharmacological target for inflammatory bowel disease. Biochem. Pharmacol. 2004, 68:2317-2326.
45. Ballester I., Gonzalez R., Nieto A., Zarzuelo A., Sanches de Medina F. Monochloramine induces acute and protracted colitis in the rat: response to pharmacological treatment. Life Sci. 2005, 76:2965-2980.
46. Ohshima H., Yoshie Y., Auriol S., Gilibert I. Antioxidant and pro-oxidant actions of flavonoids: effects on dna damage induced by nitric oxide, peroxynitrite and nitroxyl anion. Free Radic. Bio. Med. 1998, 1057-1065.
47. Skibola F.C., Smith M.T. Potential health impacts of excessive flavonoid intake. Free Radic. Bio. Med. 2000, 29:375-383.
48. Cruz T., Gálvez J., Crespo E., Ocete M.A., Zarzuelo A. Effects of silymarin on the acute stage of the trinitroenzenesulphonic acid model of rat colitis. Planta Med. 2001, 67:94-96.
49. Crespo M.E., Gálvez J., Cruz T., Ocete M.A., Zarzuelo A. Anti-inflammatory activity of diosmin and hesperidin in rat colitis induced by TNBS. Planta Med. 1999, 65:651-653.
50. Garcia-Argaez A.N., Apan T.O.R., Delgado H.P., Velasquez G., Martinez-Vazquez M. Anti-inflammatory activity of coumarins from Decatropis bicolor on TPA ear mice model. Planta Med. 2000, 66:279-281.
51. Sies H. Glutathione and its role in cellular functions. Free Radic. Biol. Med. 1999, 27(9-10):916-921.
52. Morgenstern I., Raijmakers M.T.M., Peters W.H.M., Hoensch H., Kirch W. Homocysteine cysteine, and glutathione in human colonic mucosa. Dig. Dis. Sci. 2003, 2083-2090.
53. Camuesco D., Peran L., Comalada M., Nieto A., Di Stasi L.C., Rodriguez-Cabezas M.E., Concha A., Zarzuelo A., Gálvez J. Preventative effects of lactulose in the trinitrobenzenesulphonic acid modelo f rat colitis. Inflamm. Bowel Dis. 2005, 11(3):265-271.
54. Loguercio C., D'Argenio G., Delle Cave M., Cosenza V., Della Valle N., Mazzacca G., Del Vecchio Blanco C. Glutathione suplementation improves oxidative damage in experimental colitis. Dig. Liver Dis. 2003, 35(9):635-641.
55. Yamada T., Grisham M.B. Pathogenesis of tissue injury: role of reactive metabolites of oxygen and nitrogen. Inflammatory Bowel Disease: From Bench to Beside 1994, 133-150. Williams & Wilkins, Baltimore. S.R. Targan, F. Shanahan (Eds.).
56. Cestari S.H., Bastos J.K., Di Stasi L.C. Intestinal anti-inflammatory activity of Baccharis dracunculifolia in the trinitrobenzenesulphonic acid model of rat colitis. Evid.-Based Compl. Alt. 2009, 1-9.
57. Neichi T., Koshihara Y., Mutora S.I. Inhibitory effects of esculetin on lipoxygenase and leukotriene biosynthesis. Biochim. Biophys. Acta 1983, 753:130-132.
58. Loggia R.D., Ragazzi E., Tubaro A., Fassina G., Vertua R. Anti-inflammatory activity of benzopyrone that are inhibitors of cyclo- and lipoxygenase. Pharmacol. Res. Commun. 1988, 20:91-94.
59. Hoult J.R.S., Payá M. Pharmacological and biochemical actions of simple coumarins: natural products with therapeutical potential. Gen. Pharmacol. 1996, 27(4):713-722.
60. Sharma S.D., Rajor H.K., Chopra S., Sharma R.K. Studies on structure activity relationship of some dihydroxy-4-methylcoumarin antioxidants based on their interaction with Fe (III) and ADP. BioMetals 2005, 18:143-154.